Skip to content

Kayla Flewelling, MD

NPI 1255949046ActiveIndividual· Surgery· Buffalo, NY

Surgery (MD) in Buffalo, New York, licensed in MI and NY, with an NPI issued in July 2020. Part D covered 47 prescriptions written in 2024, 100% of them generic. Novo Nordisk Inc reported $33.79 in payments in 2025, mostly food and beverage.

Overview

NPI1255949046
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 17, 2020
Last updated in NPPESJul 19, 2026
Certified by providerJul 19, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Surgery Primary208600000X4351048018MI
Surgery208600000X346153NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - General Surgery (MI)

Part D prescriptions in 2024

Prescriptions (claims)47 · 50 30-day fills
Patients41
Total drug cost$152.30
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$33.79 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$33.791

What the 2025 payments were for

  • Food and Beverage$33.79 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Surgery providers in Buffalo

All Surgery providers in New York →